Anti-glioma response of autologous T cells stimulated by autologous dendritic cells electrofused with CD133 + or CD133 - glioma cells

Journal of Neuroimmunology

Volumn 242, Issue 1-2, 2012, Pages 9-15

  Qin, Kun ^a   Tian, Ge ^a   Li, Peng ^a   Chen, Qiang ^a   Zhang, Run ^a   Ke, Yi Quan ^a   Xiao, Zhi Cheng ^b   Jiang, Xiao Dan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

CD133; Cell fusion; Dentritic cells; Glioma stem like cells; Tumor vaccine

Indexed keywords

CD133 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CANCER CELL DESTRUCTION; CELL CULTURE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY TEST; DENDRITIC CELL; ELECTROFUSION (CELL); GLIOMA CELL; HUMAN; HUMAN CELL; HYBRID CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; BRAIN NEOPLASMS; CELL FUSION; CELLS, CULTURED; DENDRITIC CELLS; ELECTROCHEMICAL TECHNIQUES; GLIOMA; GLYCOPROTEINS; HUMANS; HYBRID CELLS; LYMPHOCYTE ACTIVATION; PEPTIDES; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED;

EID: 84856766513     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.11.001     Document Type: Article

References (35)

1. Ahmed S. The culture of neural stem cells. J. Cell. Biochem. 2009, 106:1-6.
2. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
3. Bauer N., Fonseca A.V., Florek M., Freund D., Jaszai J., Bornhauser M., Fargeas C.A., Corbeil D. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 2008, 188:127-138.
4. Baumann M., Krause M., Hill R. Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer 2008, 8:545-554.
5. Clement V., Dutoit V., Marino D., Dietrich P.Y., Radovanovic I. Limits of CD133 as a marker of glioma self-renewing cells. Int. J. Cancer 2009, 125:244-248.
6. Elkord E., Alcantar-Orozco E.M., Dovedi S.J., Tran D.Q., Hawkins R.E., Gilham D.E. T regulatory cells in cancer: recent advances and therapeutic potential. Expert. Opin. Biol. Ther. 2010, 10:1573-1586.
7. Folkins C., Shaked Y., Man S., Tang T., Lee C.R., Zhu Z., Hoffman R.M., Kerbel R.S. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res. 2009, 69:7243-7251.
8. Gilboa E. DC-based cancer vaccines. J. Clin. Invest. 2007, 117:1195-1203.
9. Golovina T.N., Vonderheide R.H. Regulatory T cells: overcoming suppression of T-cell immunity. Cancer J. 2010, 16:342-347.
10. Gong J., Avigan D., Chen D., Wu Z., Koido S., Kashiwaba M., Kufe D. Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2715-2718.
11. Hadjipanayis C.G., Van Meir E.G. Tumor initiating cells in malignant gliomas: biology and implications for therapy. J. Mol. Med. 2009, 87:363-374.
12. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15178-15183.
13. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N. Engl. J. Med. 2006, 355:1253-1261.
14. Koido S., Hara E., Homma S., Namiki Y., Ohkusa T., Gong J., Tajiri H. Cancer vaccine by fusions of dendritic and cancer cells. Clin. Dev. Immunol. 2009, 2009:657369.
15. Koido S., Homma S., Hara E., Namiki Y., Ohkusa T., Gong J., Tajiri H. Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells. J. Biomed. Biotechnol. 2010, 2010:752381.
16. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:781-786.
17. Korkaya H., Wicha M.S. Cancer stem cells: nature versus nurture. Nat. Cell Biol. 2010, 12:419-421.
18. Llaguno S.A., Chen J., Kwon C.H., Parada L.F. Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:421-426.
19. Mizrak D., Brittan M., Alison M.R. CD133: molecule of the moment. J. Pathol. 2008, 214:3-9.
20. Mougiakakos D., Choudhury A., Lladser A., Kiessling R., Johansson C.C. Regulatory T cells in cancer. Adv. Cancer Res. 2010, 107:57-117.
21. Nakano I., Saigusa K., Kornblum H.I. BMPing off glioma stem cells. Cancer Cell 2008, 13:3-4.
22. Nishikawa H., Sakaguchi S. Regulatory T cells in tumor immunity. Int. J. Cancer 2010, 127:759-767.
23. Ogden A.T., Waziri A.E., Lochhead R.A., Fusco D., Lopez K., Ellis J.A., Kang J., Assanah M., McKhann G.M., Sisti M.B., McCormick P.C., Canoll P., Bruce J.N. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 2008, 62(505-514):514-515.
24. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
25. Shmelkov S.V., St C.R., Lyden D., Rafii S. AC133/CD133/Prominin-1. Int. J. Biochem. Cell Biol. 2005, 37:715-719.
26. Siders W.M., Vergilis K.L., Johnson C., Shields J., Kaplan J.M. Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells. Mol. Ther. 2003, 7:498-505.
27. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
28. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
29. Temple S. The development of neural stem cells. Nature 2001, 414:112-117.
30. Trevor K.T., Cover C., Ruiz Y.W., Akporiaye E.T., Hersh E.M., Landais D., Taylor R.R., King A.D., Walters R.E. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol. Immunother. 2004, 53:705-714.
31. Wang J., Sakariassen P.O., Tsinkalovsky O., Immervoll H., Boe S.O., Svendsen A., Prestegarden L., Rosland G., Thorsen F., Stuhr L., Molven A., Bjerkvig R., Enger P.O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 2008, 122:761-768.
32. Wei J., Barr J., Kong L.Y., Wang Y., Wu A., Sharma A.K., Gumin J., Henry V., Colman H., Sawaya R., Lang F.F., Heimberger A.B. Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 2010, 16:461-473.
33. Yamanaka R. Dendritic-cell- and peptide-based vaccination strategies for glioma. Neurosurg. Rev. 2009, 32(265-273):273.
34. Yamanaka R., Homma J., Yajima N., Tsuchiya N., Sano M., Kobayashi T., Yoshida S., Abe T., Narita M., Takahashi M., Tanaka R. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin. Cancer Res. 2005, 11:4160-4167.
35. Yu J.S., Liu G., Ying H., Yong W.H., Black K.L., Wheeler C.J. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res. 2004, 64:4973-4979.